ACTRN12606000272594已完成不适用
A double-blinded, placebo-controlled trial of modafinil for amphetamine withdrawal in adults who are currently dependent on amphetamines
Government Department of Health and Aging.0 个研究点目标入组 20 人开始时间: 2006年7月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Meets the Diagnostic and Statistical Manual for Mental Disorders No. 4 (DSM-IV) diagnosis of current amphetamine dependence, Has used amphetamines in previous 48 hours, Is seeking treatment for amphetamine dependence, Is willing and able to give informed consent.
排除标准
- •Currently dependent on other psychoactive drugs other than amphetamines, cannabis or nicotine, Has any significant unstable medical conditions, Is pregnant or breastfeeding, Is suffering from active psychosis or current major depression, Is diagnosed with attention deficit hyperactivity disorder or narcolepsy, Is known to have had an allergic reaction to modafinil previously, Has had treatment with dexamphetamine or modafinil in the previous month.
研究者
相似试验
尚未招募
4 期
The effect of proton pump inhibitor on mycophenolic acid absorption in kidney and liver transplant recipientsDrug interactionRenal and Urogenital - Kidney diseaseACTRN12611000316909Health Department of Western Australia42
招募中
3 期
The influence of modafinil on the post-exercise exacerbation of symptoms in patients with chronic fatigue syndromechronic fatigue syndromeOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12616000487415niversity of New South Wales20
已完成
不适用
A double-blind, placebo-controlled trial of methylphenidate in children with hyperkinetic disorder and moderate-severe learning disabilitiesISRCTN68384912King's College London (UK)180
招募中
不适用
The effect of melatonin on insomnia of cancer patientsKCT0003362Asan Medical Center60
进行中（未招募）
1 期
Dose-ranging study to assess the efficacy, safety, and tolerability of SAR440340 (anti-IL-33 mAb) in patients with moderate-to-severe asthmaMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2019-003751-10-ITSANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT1,120